Steven E. McKenzie MD PhD
Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias
Professor, Medicine and Pediatrics, Sidney Kimmel Medical College-Thos Jefferson Univ
Join to view full profile
1015 Chestnut StSte 1321Philadelphia, PA 19107
Phone+1 215-955-4730
Fax+1 215-503-9188
Dr. McKenzie is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven McKenzie is a hematologist in Philadelphia, PA. He received his medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 32 years. He specializes in clotting disorder, hemophilia & bleeding disorder, and sickle cell & other anemias and is experienced in thalassemias, platelet disorders, hemophilia a, hemophilia, and sickle cell disease.
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1988 - 1991- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1985 - 1988
University of PennsylvaniaPhD, Bioengineering, 1978 - 1985
Perelman School of Medicine at the University of PennsylvaniaClass of 1985
Certifications & Licensure
PA State Medical License 1986 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012, 2014-2017
Publications & Presentations
PubMed
- Heparin-induced thrombocytopenia immune complexes activate the inflammasome pathway in a complement-dependent manner.James V Michael, Sanjay Khandelwal, Antonios Tawk, Sophia Lazar, C Garren Hester
Journal of Thrombosis and Haemostasis. 2026-06-01 - VLX-1005, but not argatroban, prevents ITAM-mediated platelet activation and heparin-induced thrombocytopenia.Adriana Yamaguchi, Victoria Putzbach, Reheman Adili, Sophia Lazar, Livia Stanger
Blood Vessels, Thrombosis & Hemostasis. 2026-05-01 - 3 citationsUnderstanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk.Yanki Yarman, Xuefei Zhao, Hyunsook Ahn, Hannah Thomson, Amrita Sarkar
Blood. 2026-04-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
